Aino Health interim report January-June 2019
12 August 2019
Aino Health interim report January-June 2019
- Increased net sales, improved profit, net sales and cash flow, the business model is showing results
• Net sales increased by 18 percent to SEK 5,677,000 (4,800,000)*
• Profit after financial items improved to SEK -4,880,000 (-5,824,000)
• Earnings per share improved to SEK -0.3 (-1.1)
• Net sales increased by 17 percent to SEK 11,529,000 (9,875,000)*
• Profit after financial items improved to SEK -8,144,000 (-13,099,000)
• Earnings per share improved to SEK -0.5 (-2.4)
* The company has about SEK 1.5 million in accounts receivable from result-based contracts, accrued during Q42018–Q22019 and not yet taken up as revenue.
During the second quarter, we have retained our focus on sales, through both direct sales and partnerships. We have created the conditions for several new customers and partners. We can see that our partnership model works well, and after the quarter, our efforts have borne fruit in the form of new partnerships.
Going into the 2nd half of 2019, we have a good momentum in the sales pipeline, which looks very promising. In both Sweden and Germany, we are in negotiations with multi-national corporations with more than 500.000 employees in total. The negotiations are moving forward in a positive manner, but as always, the sales cycles for these kinds of negotiations take time, nevertheless we can see that our cash flow is improving significantly compared to previous quarters.
Another strong focus area going forward is to build a global footprint and a large part of this is to explore the opportunity to create partnerships and collaborations with universities and other entities in the academic world.
Our business model shows results
After the end of the quarter, we have signed a partnership agreement with Aava Finland, one of Finland's largest suppliers of corporate healthcare, regarding the sale of Aino HealthManager and associated services. During the month of July, we have also signed agreements with EFESO Consulting Nordics and 55Birchstreet GmbH.
We continue to work with partners on all our primary markets. This is an important strategic signal from us to our customers and partners.
Still, we have also continued to interact directly with our customers. We have signed a direct agreement with one of Sweden's oldest cleaning companies, Rahms. The agreement has a term of two years and encompasses implementation services and licenses for Aino HealthManager. We have also extended and expanded our agreement with the German company ArcelorMittal following successful performance of a pilot project with Aino HealthManager.
Our business model, with a combination of result-based remuneration and fixed fees, has been successful. We are now starting to reap the benefits and can see that the revenue will keep pace quarterly during the contract period.
High expectations for the second half 2019
We have about SEK 1.5 million in accounts receivable from a result-based contract, as formerly communicated. This has not been taken up as revenue; we plan to start gradually taking it up as revenue during the third quarter. The agreement states that the receivables will be paid to us, after project evaluation, during the fourth quarter 2021, given that the outcome of the contract is on par with what it has been thus far.
During the beginning of the year, we signed a deal with an American IT company regarding its operations in Finland. The contract encompasses about SEK 28 million and will have a substantial impact on our net sales, profit, and cash flow.
The financial results will be taken up as revenue starting from the third quarter and cash flow will be positively impacted starting from the fourth quarter.
We are seeing a large interest in our solutions and services. Given the deals gained and that the financial impact of these will start to be visible in our income statement as of the third quarter, I look forward to a positive second half of 2019.
CEO and President
Aino Health AB
The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CEST on August 12 2019.
För mer information:
Jyrki Eklund, CEO Aino Health, Phone: +358 40 042 4221
Erik Penser Bank
+46 8 463 83 00
About Aino Health (publ)
Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq Stockholm First North (Ticker: AINO).
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Cypress Development Files Prefeasibility Study for Clayton Valley Lithium Project in Nevada3.6.2020 21:13:48 CEST | Press release
VANCOUVER, British Columbia, June 03, 2020 (GLOBE NEWSWIRE) -- Cypress Development Corp. (TSX-V:CYP) (OTCQB:CYDVF) (Frankfurt:C1Z1) (“Cypress” or “the Company”) is pleased to announce, further to its News Release on May 19, 2020, the full Prefeasibility Study (PFS) of the Clayton Valley Lithium Project in Nevada, U.S.A. was filed on SEDAR and is available on the Company’s web site. The PFS was prepared by Continental Metallurgical Services (CMS) and Global Resource Engineering (GRE) and has an Effective Date of May 19, 2020. Todd Fayram (CMS), Terre Lane (GRE), and Daniel Kalmbach are the authors. Highlights from the PFS and news release are as follows: Average production rate of 15,000 tonnes per day to produce 27,400 tonnes lithium carbonate equivalent (LCE) annually over a +40-year mine life. Capital cost estimate of US$493 million, pre-production, and operating cost estimate averaging US$3,329* per tonne LCE. (* see Note) After-tax net present value at an 8% discount rate (NPV-8%)
Cleantech Building Materials: Notice of AGM3.6.2020 18:55:17 CEST | Press release
3 June 2020 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM CLEANTECH BUILDING MATERIALS PLC Notice of AGM Cleantech Building Materials plc ("CBM" or the "Company") confirms that the Annual General Meeting will be held on 26 June 2020 at 11.00am at 19 Colville Mews, London, W11 2DA. Copies of the following documents have today been posted to the Company’s shareholders: 1. Circular to shareholders of the Company, including notice of the Annual General Meeting of the Company; 2. Form of proxy for use at the Annual General Meeting; and 3. Annual Results of the Company for the year ended 31 December 2019. A copy of the Circular and the Form of Proxy are attached to this release. Further information including the Circular, the Form of Proxy and the Annual Results may be found at the Company's website at www.cbm-plc.com COVID-19 – AGM Arrangements Due to the ongoing UK Government "stay at home measures" which currently include a prevention of public
Arion Bank: Covered bond offering results3.6.2020 18:53:06 CEST | Press release
Today Arion Bank hf. concluded the sale of two covered bond series. In total, 24 bids were received in the auction for the amount of ISK 2,980 million. The inflation-linked series ARION CBI 26 attracted 17 bids of ISK 2,400 million at a yield of 0.62-0.70%. Bids for nominal amount of ISK 1,000 million at a yield of 0.65% were accepted. The size of the series following the issuance will be ISK 17,080 m. The fixed rate series ARION CB 24 attracted 7 bids of ISK 580 million at a yield of 2.54–2.58%. All bids were rejected at this time. The issued bonds are scheduled to be admitted to trading on Nasdaq Iceland on 10 June 2020. For further information please contact Investor relations, at firstname.lastname@example.org
Medtronic CEO Geoff Martha to Speak at Goldman Sachs Global Healthcare Conference3.6.2020 17:00:10 CEST | Press release
DUBLIN, June 03, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 41st Annual Global Healthcare Conference, held virtually on Tuesday, June 9, 2020. Geoff Martha, Medtronic chief executive officer, will answer questions about the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT). A live audio webcast of the session will be available on June 9, 2020, by clicking on the Investor Events link at http://investorrelations.medtronic.com, and an archive of the session will be available on the same webpage later in the day. About Medtronic Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than
Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors3.6.2020 16:30:00 CEST | Press release
Vaisala Corporation Stock exchange release June 3, 2020 at 5:30 p.m. (EEST) Resolutions by Vaisala Corporation Annual General Meeting and the Board of Directors Vaisala Corporation’s Annual General Meeting was held on June 3, 2020. The meeting approved the financial statements and discharged the members of the Board of Directors and the President and CEO from liability for the financial period January 1–December 31, 2019. Dividend The Annual General Meeting decided a dividend of EUR 0.61 per share. The record date for the dividend payment is June 5, 2020, and the payment date is June 12, 2020. Board of Directors The Annual General Meeting confirmed that the number of Board members is eight. Petri Castrén, Petra Lundström, Jukka Rinnevaara, Kaarina Ståhlberg, Tuomas Syrjänen, Raimo Voipio and Ville Voipio will continue as members of the Board of Directors. Antti Jääskeläinen was elected as a new member of the Board of Directors. The Annual General Meeting confirmed that that the annual
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING3.6.2020 16:20:00 CEST | Press release
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING 2020-06-05 Transaction type:SEK CreditTender date:2020-06-05Time for submission of bids:10.00-10.30 (CEST)Payment date:2020-06-09Final repayment date2022-06-09Offered volume:50 bn SEKMinimum bid amount:10 mln SEKMaximum bid amount:12.5 bn SEKMaximum number of bids from each participant: 1Interest rate:0.00 %Supplemental interest rate 0.20 percentage points ALL APPROVED COUNTERPARTIES ARE INVITED TO SUBMIT VOLUME BIDS TO THE RIKSBANK (46-8-6966970) BY 10.30 ON JUNE 5 2020, AT THE LATEST. Result of the auction will be published at 11.00 (CEST) on Tender date. Complete terms and conditions can be retrieved at http://www.riksbank.se